Dhampur Bio Organics Publishes Notice for IEPFA's Saksham Niveshak 2.0 Campaign

1 min read     Updated on 30 Apr 2026, 07:19 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics Limited published a regulatory notice on April 29, 2026, regarding IEPFA's Second 100 days Campaign 'Saksham Niveshak 2.0' running from April 1 to July 9, 2026. The campaign urges shareholders to update KYC details, bank mandates, and contact information while claiming unpaid dividends from FY 2022-23 to 2024-25 to prevent share transfers to IEPF. The company provided comprehensive contact details for both the company secretary and registrar to assist shareholders with queries and compliance requirements.

powered bylight_fuzz_icon
39059395

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics Limited has published a regulatory notice in Business Standard newspaper dated April 29, 2026, informing shareholders about the Investor Education and Protection Fund Authority's (IEPFA) relaunched campaign. The notice was published pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Campaign Details and Timeline

The IEPFA has relaunched its Second 100 days Campaign titled 'Saksham Niveshak 2.0' effective from April 1, 2026 to July 9, 2026. This initiative aims to educate and protect investor interests by encouraging active participation in maintaining updated records and claiming rightful benefits.

Shareholder Action Items

The campaign requests shareholders to undertake three key actions:

Action Item Details
KYC Updates Update Permanent Account Number, Specimen Signatures
Bank Mandate Updates Bank Name, Branch Name & Address, Bank Account Number, IFSC Code
Contact Information Postal Address, Email and Telephone Numbers
Nominee Details Update or add nominee information

Additionally, shareholders are encouraged to verify their holdings and claim any unpaid dividends or shares that may have been transferred to the Investor Education and Protection Fund (IEPF).

Dividend Claims Priority

The notice specifically emphasizes claiming unclaimed dividends from FY 2022-23 to 2024-25 to prevent shares from being transferred to the Investor Education and Protection Fund Authority (IEPFA). This proactive approach helps shareholders retain ownership of their investments.

Contact Information for Assistance

Shareholders requiring assistance or facing issues related to unclaimed dividends and shares can contact the company or its Registrar and Share Transfer Agents:

Contact Type Details
Company Secretary Mrs. Ashu Rawat, Dhampur Bio Organics Limited
Office Address Second Floor, 201 Okhla Industrial Estate, Phase - III, New Delhi - 110020
Phone 011-6905 5200
Email investors@dhampur.com
Registrar (RTA) Details
Company Name M/s Alankit Assignments Limited
Address Alankit House, 205-208 Anarkali Complex, Jhandewalan Extension, New Delhi - 110 055
Phone 011 - 42541234, 23541234
Email rt@alankit.com , info@alankit.com

Regulatory Compliance

The newspaper publication demonstrates the company's commitment to regulatory compliance and transparent communication with shareholders. The notice was digitally signed by Company Secretary & Compliance Officer Ashu Rawat on April 29, 2026, ensuring proper authorization and documentation of the disclosure.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.70%+8.84%+17.94%+52.46%+74.21%-25.59%

How might the success of the 'Saksham Niveshak 2.0' campaign impact SEBI's future regulatory framework for investor protection?

What percentage of Dhampur Bio Organics' unclaimed dividends from FY 2022-25 could potentially be recovered through this campaign?

Will other listed companies follow similar proactive approaches to prevent share transfers to IEPF, and how might this trend affect market liquidity?

Dhampur Bio Organics Publishes EGM Notice for ₹305 Cr Business Transfer

3 min read     Updated on 25 Apr 2026, 02:14 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dhampur Bio Organics has published its EGM notice in Business Standard confirming the May 18, 2026 meeting for shareholder approval of the ₹305 crore Meerganj unit transfer and key leadership transitions. The notice provides comprehensive e-voting procedures and confirms electronic dispatch completion on April 24, 2026.

powered bylight_fuzz_icon
38371201

*this image is generated using AI for illustrative purposes only.

Dhampur Bio Organics Limited has published its Extraordinary General Meeting notice in Business Standard on April 25, 2026, confirming the EGM scheduled for Monday, May 18, 2026, at 4:00 PM IST through video conferencing. The meeting seeks shareholder approval for strategic business decisions including a major business transfer worth ₹305.00 crores and key leadership changes.

Business Transfer Proposal

The board proposes to transfer the Meerganj sugar manufacturing unit located at Bareilly, Uttar Pradesh, to Forever Global Enterprises Limited on a slump sale basis for a lump sum consideration of ₹305.00 crores. The transfer includes all assets and liabilities of the unit as a going concern, based on an independent valuer's report. The Meerganj unit contributes 15.52% to the company's total turnover, representing ₹423.24 crores out of ₹2,714.40 crores as per audited financial statements for March 31, 2025.

Parameter: Details
Consideration Amount: ₹305.00 crores
Unit Location: Meerganj, Bareilly, Uttar Pradesh
Buyer: Forever Global Enterprises Limited
Transaction Type: Slump sale basis
Turnover Contribution: 15.52% (₹423.24 crores)

The board believes the transfer will enable the company to focus on high-margin value-added businesses, become cash surplus and net debt free, and improve overall financial efficiency. The sale proceeds will primarily be used to repay and optimise company debts and maintain financial corpus for future growth opportunities.

Leadership Changes

Mr. Sandeep Kumar, currently Whole-time Director, will transition to Non-Executive Non-Independent Director effective May 5, 2026, upon completion of his tenure. He brings over 45 years of experience in operations, projects, and administration.

Mr. Nalin Kumar Gupta, currently Chief Financial Officer, has been appointed as Additional and Whole-time Director for a three-year term from May 5, 2026, to May 4, 2029. A Chartered Accountant with around 30 years of experience, he has been associated with the company for more than 25 years.

Proposed Remuneration Package

The board has proposed the following annual remuneration for Mr. Nalin Kumar Gupta as Whole-time Director:

Component: Amount (per annum)
Basic Salary: ₹44,55,240
House Rent Allowance: ₹22,27,620
Other Allowances: ₹18,30,732
Conveyance: Company maintained vehicle with driver

Additional benefits include leave encashment, leave travel allowance, performance-linked variable pay, ESOP, provident fund, and gratuity as per company policy and applicable laws. The remuneration package includes provisions for annual increases of up to 10%.

EGM and Voting Details

The company has completed electronic dispatch of the EGM notice to shareholders on Friday, April 24, 2026. The remote e-voting period commences on Thursday, May 14, 2026, at 9:00 AM and concludes on Sunday, May 17, 2026, at 5:00 PM. Shareholders whose names appear in the Register of Members as of the cut-off date of May 11, 2026, are eligible to vote.

EGM Parameter: Details
Meeting Date: Monday, May 18, 2026 at 4:00 PM
Mode: Video Conferencing/OAVM
Notice Dispatch: April 24, 2026
E-voting Period: May 14-17, 2026
Cut-off Date: May 11, 2026
Scrutinizer: Mr. Saket Sharma, GSK & Associates

The EGM will be conducted through VC/OAVM without physical attendance, in compliance with MCA and SEBI circulars. The business transfer requires approval through a special resolution under Section 180(1)(a) of the Companies Act, 2013, and Regulation 37A of the SEBI Listing Regulations. The leadership appointments require ordinary and special resolutions as applicable. The scrutinizer for the EGM is Mr. Saket Sharma, Partner, M/s GSK & Associates.

Historical Stock Returns for Dhampur Bio Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.70%+8.84%+17.94%+52.46%+74.21%-25.59%

How will the divestiture of the Meerganj unit impact Dhampur Bio Organics' sugar production capacity and market position in the competitive sugar industry?

What specific high-margin value-added businesses does Dhampur Bio Organics plan to focus on with the proceeds from this asset sale?

Could this transaction signal a broader consolidation trend in India's sugar manufacturing sector, and might other players follow similar divestiture strategies?

More News on Dhampur Bio Organics

1 Year Returns:+74.21%